Eastman Chemical CO

Eastman Chemical Company announced robust second-quarter 2026 financial results, showcasing sequential EPS growth and solid cash flow driven by operational excellence and strategic advancements.

Eastman Chemical Company's 2026 Annual Meeting saw the election of directors, ratification of auditors, and votes on executive compensation and stock plans.

Eastman Chemical Company announced its fourth-quarter and full-year 2025 financial results, highlighting strong cash generation and cost reduction efforts despite a challenging chemical industry environment.

Eastman Chemical Company reported strong operating cash flow and significant inventory reduction in Q3 2025, despite an 11% decline in sales revenue and lower earnings per share due to a persistent weak macroeconomic environment.

Eastman Chemical Company announces the retirement of its Chief Technology and Sustainability Officer and the return of a former executive to fill the role.

Eastman Chemical Company announced second quarter 2025 financial results, showing resilient earnings in specialty businesses despite macroeconomic challenges, tariff impacts, and an unplanned outage in Chemical Intermediates.

Eastman Chemical reports a 10% increase in Q2 sales driven by volume and price, but net earnings saw a decline compared to the prior year.

Eastman Chemical Company reported a significant decline in first-quarter net earnings and EBIT, driven by lower sales volume, reduced selling prices, and challenging market conditions across several segments.

Eastman Chemical Company reports significant declines in sales and profitability for the third quarter and first nine months of 2025, driven by broad market weakness and increased tax provisions.

Eastman Chemical Company reported a significant decline in second-quarter and first-half 2025 sales and earnings, primarily due to lower sales volume, reduced selling prices, and an unplanned outage in its Chemical Intermediates segment.

Eastman Chemical Company reports its first quarter 2025 financial results, including sales of $2.29 billion and adjusted earnings per share of $1.91, while also amending its executive severance agreement and unit performance plan.

Eastman Chemical Company saw a 9% increase in sales revenue in the third quarter of 2024 compared to the same period last year, primarily due to higher sales volume across all segments.

Eastman Chemical Company reported a 7% decrease in sales and a 39% drop in EBIT for 2025, driven by lower volumes and higher costs, while continuing to advance its molecular recycling and sustainability platforms.

Eastman Chemical's 2024 results show increased sales revenue but a slight decrease in EBIT, driven by strategic shifts and market dynamics.

Eastman Chemical Company has entered into a third amended and restated five-year credit agreement for $1.5 billion, enhancing its financial flexibility.

Adrian James Holt, SVP and Chief HR Officer of Eastman Chemical Company, reported transactions involving restricted stock units and common stock.

Director Humberto P. Alfonso of Eastman Chemical Co. (EMN) has reported transactions related to phantom stock units and deferred compensation.

Brett D. Begemann, a Director at Eastman Chemical Co., reported the acquisition of unvested phantom stock units valued at $73.69 each, totaling 1,628 units, under the Directors' Deferred Compensation Plan.

Kim Ann Mink, a Director at Eastman Chemical Co., reported transactions involving phantom stock units and common stock.

Director Donald W. Slager acquired 1,628 shares of Eastman Chemical Company common stock through a restricted stock award.

Julie Fasone, a Director at Eastman Chemical Co., acquired 1,628 restricted shares on May 7, 2026, as part of her annual Restricted Stock Award.

Eastman Chemical Company reported significant declines in 2025 financial performance, a negative S&P outlook, and faces environmental lawsuits, despite operational gains in cash flow and safety.

Eastman Chemical Company will hold its 2025 Annual Meeting of Stockholders virtually on May 1, 2025, to vote on director elections, ratification of the accounting firm, executive compensation, and a stockholder proposal.

Eastman Chemical's 2025 proxy statement outlines the company's strategic priorities, governance practices, and executive compensation, emphasizing sustainable growth and stockholder value.

Eastman Chemical Company will hold its annual meeting of stockholders virtually on May 2, 2024, to elect directors, ratify the appointment of PricewaterhouseCoopers LLP, and conduct an advisory vote on executive compensation.

Eastman Chemical's 2024 proxy statement outlines the company's commitment to sustainable growth, innovation, and shareholder value through strategic initiatives and strong financial performance.

Vanguard Capital Management has filed a Schedule 13G reporting a 5.22% beneficial ownership stake in Eastman Chemical Co.

Vanguard Portfolio Management has disclosed a beneficial ownership of 6.7% in Eastman Chemical Company's common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G for Eastman Chemical Co, reporting 0% beneficial ownership due to an internal organizational realignment.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 11.9% in Eastman Chemical Co.

Capital Research Global Investors filed an amendment to its Schedule 13G, disclosing a 3.7% beneficial ownership stake in Eastman Chemical Co.

Franklin Resources, Inc. reports a 3.9% beneficial ownership stake in Eastman Chemical Company common stock in an amended Schedule 13G filing.